by admin_63069 | Jan 22, 2022 | Related Topics
The Exablate Prostate system, guided by MRI technology, directs sound waves toward cancerous prostate tissue, destroying only the malignant tissue and preserving the healthy structures nearby.
by admin_63069 | Jan 19, 2022 | Related Topics
View this presentation by Robert E. Reiter, MD, during the 31st International Prostate Cancer Update in July 2021 in Snowbird, Utah.
by admin_63069 | Jan 16, 2022 | Related Topics
TLX591-CDx is the first commercially available product approved by the FDA that will broaden access to 68Ga-based PSMA-PET imaging for patients within the United States who are eligible to receive it.
by admin_63069 | Jan 13, 2022 | Related Topics
In this presentation, Dr. Phillip Kuo, MD, Ph.D., Professor of Medical Imaging, Medicine and Biomedical Engineering, the University of Arizona and Senior Medical Director, presents on theranostics and its role in prostate cancer treatment.
by admin_63069 | Jan 10, 2022 | Related Topics
In this video, Dr. Morgans discusses the key points of her presentation, “Advanced disease: incorporating molecular markers and genomic studies into therapy,” presented recently at the 2021 Society of Urologic Oncology Annual Meeting.
by admin_63069 | Jan 7, 2022 | Related Topics
In this video, Gerald L. Andriole, MD, discusses the background and findings of a study presented recently at the 2021 Society of Urologic Oncology Annual Meeting.
